Rchr
J-GLOBAL ID:201801019152538333   Update date: Jul. 12, 2024

Shibuta Tatsuki

Shibuta Tatsuki
Affiliation and department:
Research field  (3): Hematology and oncology ,  Internal medicine - General ,  Nutrition and health science
Research keywords  (9): Extracellular Vesicles ,  生活習慣病 ,  Myeloproliferative Neoplasms ,  Myelodysplastic Syndrome ,  clonal hematopoiesis of indeterminate potential ,  核酸塩基修飾 ,  Epigenetics ,  検査血液学 ,  血液学
Research theme for competitive and other funds  (4):
  • 2024 - 2027 Development of an early diagnosis of vascular endothelial cell injury in lifestyle-related diseases using highly sensitive extracellular vesicle analysis.
  • 2022 - 2024 細胞外小胞表面抗原の網羅的解析による新規臨床検査法の開発
  • 2019 - 2022 Analysis between RNA modification and pathogenesis in myelodysplastic syndromes
  • 2017 - 2019 Elucidation of cell-cell interaction in myelodysplastic syndromes via tumor exosome
Papers (14):
  • Kanyarat Boonpeng, Tatsuki Shibuta, Yoshitaka Hirooka, Kasem Kulkeaw, Duangdao Palasuwan, Tsukuru Umemura. Serum microRNAs as new biomarkers for detecting subclinical hemolysis in the nonacute phase of G6PD deficiency. Scientific Reports. 2024. 14. 1
  • 梅村創, 澁田樹, 髙田勇吉. 臨床化学検査における新しい検査法:循環microRNA(miRNA). 臨床病理レビュー. 2023. 166. 215-226
  • Tatsuki Shibuta, Honoka Shimizu, Yukichi Takada, Asuka Fuku, Satoshi Tomiyasu, Tsukuru Umemura. miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors. Hemato. 2022. 3. 2. 373-384
  • Yukichi Takada, Tatsuki Shibuta, Mayu Hatano, Kenichi Sato, Mari Koga, Ayaka Ishibashi, Tetsuhiro Harada, Takashi Hisatomi, Hanae Shimura, Noriyasu Fukushima, et al. Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases. Journal of Clinical Medicine. 2021. 10. 21. 5045-5045
  • 富安 聡, 三宅 康之, 大塚 百華, 四丸 知弥, 澁田 樹, 宿谷 賢一, 大田 喜孝, 佐藤 信也. 過ヨウ素酸を媒染剤に用いた新規azan-Mallory染色. 臨床検査. 2020. 64. 7. 817-821
more...
MISC (3):
  • Surface Plasmon Resonance Method detects Circulating EVs as biomarkers for Hypertension and Type 2 Diabetes Mellitus. 2023
  • 神尾成美, 澁田樹, 福島伯泰, 梅村創, 梅村創, 富安聡, 志村華絵. 健常人におけるEosin-5-Maleimide(EMA)結合能検査の条件検討. 日本検査血液学会雑誌. 2018. 19. 学術集会. S189-S189
  • Umemura Tsukuru, Tatsuki Shibuta. Exosome microRNA in Erythropoiesis. A Special Symposium “Extracellular Vesicle: Research Focus and Clinical Applications” (Thailand). 2018
Patents (1):
  • 細胞外小胞表面分子を用いた疾患の検査方法及び検査キット
Lectures and oral presentations  (42):
  • MiR-451 and miR-16 as new biomarkers to predict the severity of G6PD deficiency
    (2023)
  • RNA修飾酵素異常を標的とした慢性造血器腫瘍の新規診断法の開発
    (国際医療福祉大学学会 2023)
  • MiR-451a is a sensitive biomarker to detect subclinical hemolysis in patients with G6PD deficiency
    (2023)
  • 学生教育における尿中赤血球形態の理解度調査
    (日本臨床検査学教育学会学術大会 2023)
  • 九州支部内施設での遺伝子関連・染色体検査の実施状況調査
    (日臨技九州支部医学検査学会 2022)
more...
Professional career (1):
  • 博士(保健学) (九州大学)
Work history (3):
  • 2023/04 - 現在 International University of Health and Welfare School of Health Sciences at Fukuoka Department of Medical technology and Sciences
  • 2021/04 - 2023/03 International University of Health and Welfare School of Health Sciences at Fukuoka Department of Medical technology and Sciences
  • 2017/01 - 2021/03 International University of Health and Welfare School of Health Sciences at Fukuoka, Department of Medical technology and Sciences
Awards (2):
  • 2022/08 - 優秀演題賞 造血器腫瘍細胞による骨髄微小環境の破綻メカニズムの解明 第12回国際医療福祉大学学会学術大会
  • 2020/10 - 第10回国際医療福祉大学学会学術大会 優秀演題賞 Direct RNA-seqを用いた腫瘍細胞中RNA修飾の解明
Association Membership(s) (7):
JAPANESE SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS ,  JAPAN CYTOMETRY SOCIETY ,  JAPANESE SOCIETY FOR LABORATORY HEMATOLOGY ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  JAPANESE SOCIETY OF LABORATORY MEDICINE ,  JAPANESE ASSOCIATION OF MEDICAL TECHNOLOGISTS ,  臨床化学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page